ArticleAbdominal radiology (New York)2026
Measurement of renal tumor size: the impact of 2D versus 3D methods on the T-stage.
Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
Abstract
objectivesTo investigate the influence of different tumor diameter measurement methods on the clinical T-staging of renal masses and compare this with the pathological T-staging.
methodsFour two-dimensional (2D) and two three-dimensional (3D) measurement methods (2D axial, 2D perpendicular, 2D oblique, 2D ellipsoid*, 3D diameter* and 3D volume* (*newly proposed methods)) were used to calculate the tumor diameter in 173 patient cases. 3D models of the tumors were segmented on the preoperative computed tomography (CT) scans. PyRadiomics was used to automatically analyze the 3D models for the six different measurement methods. Paired t-tests were performed to compare the tumor diameter over the different methods. Operation time (OT) and estimated blood loss (EBL) were compared between the T1a and T1b tumors for all methods using unpaired t-tests.
resultsMaximal tumor diameter results depend on the measurement method. The 3D diameter method gave the highest value, on average 16.9% larger than the pathological diameter. The 3D volume method distinguished best between T1a and T1b with regard to OT and EBL, followed by the 2D axial method. The biggest limitations are the small number of large tumors included and the single-observer measurements.
conclusionThe renal tumor diameter measured on imaging is influenced by the measurement technique and is larger than the pathological diameter. The newly proposed 3D volume method distinguishes surgical complexity best between T1a and T1b. However, when no 3D model is available, the simple diameter measurement on the axial plane could be sufficient.
Indexed as
Identifiers
41273440What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.